This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Assessing the Efficacy of Rifaximin in Diarrhea‐Predominant Irritable Syndrome (IBS‐D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo‐Controlled Trials: 482. (October 2017)
Record Type:
Journal Article
Title:
Assessing the Efficacy of Rifaximin in Diarrhea‐Predominant Irritable Syndrome (IBS‐D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo‐Controlled Trials: 482. (October 2017)
Main Title:
Assessing the Efficacy of Rifaximin in Diarrhea‐Predominant Irritable Syndrome (IBS‐D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo‐Controlled Trials